News and Trends 31 Oct 2022 Efflux pump inhibitor research may lead way to beating AMR …as penicillin or erythromycin, work by making their way into a bacterial cell. Once there, the antibiotic prevents the cell from working properly by interfering with its molecular machinery. From… October 31, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2018 Antibody Hitting Tumor Self-Destruct Button Passes Phase I …by tumor cells in cancers such as ovarian and breast cancer. The protein prevents the natural self-destruct mechanism in cells, letting tumor cells multiply unchecked by the immune system. Following… December 12, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016 What do the CAR-T Patient Deaths Mean for the Future of the Field? …such data, at least because it doesn’t push biotechs to explore their products better,” Voisin says. Voisin also points out that it’s critical for biotechs to seek unbiased advice from… December 14, 2016 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
News and Trends 20 Feb 2018 This Gene Therapy for Vision Loss is Safe and Effective After Two Years …ND4 gene, which is flanked by a Mitochondrial Targeting Sequence. At the moment, GenSight seems to be the only biotech developing a gene therapy for LHON. Instead, many biotechs look… February 20, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 13 Nov 2018 French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins …not controllable with approved drugs. By lowering blood pressure, the drug could cut the risk of life-threatening cardiovascular events such as heart attacks and strokes. The drug also showed a… November 13, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 6 Jul 2020 How Immuno-Oncology Contributes to the Fight Against Covid-19 …strains The French biotech OSE Immunotherapeutics is developing immunotherapies for oncology and autoimmune diseases. One of its technologies consists of screening and identifying the cancer antigens that are most likely… July 6, 2020 - 7 minutesmins - By Maya Chergova Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022 PerkinElmer’s Horizon Discovery: the lowdown on base editing …without loss of viability while retaining an enhanced safety profile. Michelle Fraser, business unit manager of base editing at PerkinElmer gives Labiotech the details on this new area of research. … October 17, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 8 Jan 2018 Meet the Swiss CEO Pulling Out All the Stops Against Alzheimer’s Disease …for life sciences. Pfeifer described the role as “internal entrepreneurship,” such that it didn’t seem like a huge change to move into a biotech startup. Pfeifer left Nestlé because she… January 8, 2018 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 7 Apr 2025 Will tRNA therapy be the next big thing in genetic disease treatment? …some attention within the biotech industry, with some startups making it their mission to be the first to develop successful tRNA therapies to take into the clinic. Alltrna presents positive… April 7, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 21 Apr 2021 Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain …by US-Irish biotech Amarin, recently became the first approved treatment in the EU to reduce the risk of strokes and heart attacks in patients with elevated triglycerides—a type of fat—who… April 21, 2021 - 5 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2025 Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground …lagged.” So what’s currently available for von Willebrand disease patients, what are the challenges, and how biotech is aiming to address them? Let’s find out. Table of contents Von Willebrand… January 9, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 22 Aug 2022 EpiVario looks to biotech for PTSD treatment Emerging U.S. biotech company EpiVario, Inc. has highlighted preclinical research findings that could lead to a treatment approach for post-traumatic stress disorder (PTSD). Published in Proceedings of the National Academy… August 22, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email